Name: Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve (Video) | JoVE Journal
Uploaded: 2017-06-14T14:00:00.000+00:00
Duration: 9 min 13 s
Description: Learn an optimized protein extraction protocol for the human cardiac mitral valve suitable for proteomic analysis. This method enables comprehensive proteome characterization and identification of diagnostic markers in valvular heart disease.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

playerTrialDesktop

The Italian Ministry of Health supported this study (RC 2013-BIO 15). We thank Barbara Micheli for her excellent technical assistance.

In this protocol, the human hearts are collected during multiorgan explantation (cold ischemia time of 4-12 h, mean 6 &#177; 2 h) from multi-organ donors excluded from organ transplantation for technical or functional reasons, despite normal echocardiographic parameters. They are sent to the Cardiovascular Tissue Bank of Milan, Monzino Cardiologic Center (Milan, Italy) for the banking of the aortic and pulmonary valves. The mitral posterior leaflets are not used for clinical purposes, so they are collected during the aortic and pulmonary valve isolation after informed consent is obtained from the donors&#39; relatives. The tissue for transplantation and research is collected only after parental consent; on the consent sheet, they authorize (or not) the use of the cardiac tissue for research only if it is not suitable for human clinical use (i.e., microbiological, functional, and serological problems), following the guidelines of the ethics committee of Monzino Cardiologic Center.
1. Mitral valve preparation
<ol>
	<li>Harvest the human mitral valve as soon as possible after organ explantation (cold ischemia time of 4-12 h).</li>
	<li>In a clean room, remove the heart from the transport bag containing a cold (4 &#176;C) solution (i.e., saline solution or balanced medium Eurocollins or Wisconsin). Put it into a bucket and place it in a biosafety cabinet (biohazard vertical air flow, class A, Good Manufacturing Practices (GMP) classification) to proceed with the valve preparation.</li>
	<li>Place the heart on a sterile disposable drape in the cabinet. Using a sterile disposable scalpel, cut the heart completely, perpendicularly to its major axis, on the level of the left and right ventricles, about 4 cm away from the apex.</li>
	<li>Move the ascending aorta and pulmonary artery to display the left atrial roof.</li>
	<li>With sterile autoclavable forceps and picks, cut around the left auricle on the left atrial roof, making the mitral valve visible and allowing for the great mitral leaflet (anterior) and the small mitral leaflet (posterior) to be identified. 
	NOTE: Antero-lateral and the posterior medial commissures define the border of the anterior leaflet and the posterior area.</li>
	<li>Using sterile autoclavable scissors and non-traumatic forceps, dissect the left atrium and the ventricle wall thickness around the circumference of the whole mitral valve.</li>
	<li>Identify the mitro-aortic valve continuity. 
	NOTE: The left ventricle contains the whole mitral valve and chords.</li>
	<li>Separate the anterior mitral valve leaflet from the posterior mitral valve leaflet, cutting the posterior leaflet along the insertion with the ventricle (commissure).</li>
	<li>Wash the posterior leaflet in the saline solution. Cut the leaflet into small pieces (&#60;1 cm2) and individually wrap them in aluminum foil. Snap-freeze them with liquid nitrogen. 
	Caution: Follow organizational safety procedures when using liquid nitrogen.
	<ol>
		<li>Sanitize the table of the cabinet with a 70% isopropyl alcohol solution and a 6% hydrogen peroxide solution at the end of the procedure.</li>
	</ol>
	</li>
</ol>
2. Protein extraction
<ol>
	<li>Use forceps to pick up the sample stored in liquid nitrogen and immediately place it on dry ice while still wrapped in the aluminum foil. Do not leave the sample to thaw during any transfers.</li>
	<li>Prior to grinding, chill the porcelain/zirconium mortar and pestles of a grinder system (e.g., CryoGrinder), together with the sample, by putting them in a Dewar flask containing liquid nitrogen (~500 mL). 
	Caution: Follow organizational safety procedures when using liquid nitrogen.</li>
	<li>Put the mortar and pestles in a polystyrene box containing dry ice. Remove the sample from the aluminum foil and put it into the mortar.</li>
	<li>Grind the sample with the big pestle against the mortar 15-20 times, using the screwdriver to rotate the pestle. Mix the sample with the tip of a pre-chilled spatula during the grinding process.
	<ol>
		<li>Repeat with the small pestle.</li>
	</ol>
	</li>
	<li>Transfer the ground sample to a previously weighed tube (e.g., 15 mL centrifuge tube) by inverting the tube, placing it over the mortar, and inverting them together to move the sample to the tube. Use a pre-chilled spatula to recover all material from the mortar.
	<ol>
		<li>Keep the tube with the sample on dry ice to avoid sample thawing during the transfer.</li>
	</ol>
	</li>
	<li>Calculate the net weight of the sample.</li>
	<li>Clean the mortar and the pestles after each sample and decontaminate them by autoclaving or heating them at 200 &#176;C for 2 h.</li>
	<li>Transfer the powdered sample from the centrifuge tube to the glass tube of a homogenizer by inversion.</li>
	<li>Add filtered urea buffer (8 M urea, 2 M thiourea, 4% w/v CHAPS, 20 mM Tris, and 55 mM dithiotreitol) to the glass tube, 200 &#181;L of urea buffer for every 10 mg of powdered tissue. 
	NOTE: Residual powdered sample left in the centrifuge tube can be recovered using part of the calculated volume of urea buffer.</li>
	<li>Homogenize the sample using a stirrer equipped with a borosilicate glass mortar and a polytetrafluoroethylene (PTFE) pestle. Slowly press the pestle onto the sample with a twisting motion (1,500 rpm) 10 times.</li>
	<li>Recover the supernatant and transfer it to a clean 1.7 mL centrifuge tube. Again extract the remaining sample with fresh urea buffer, adding half of the volume used during the first extraction.</li>
	<li>Repeat step 2.10.</li>
	<li>Recover the supernatant and combine it with the supernatant from step 2.11. Place the combined supernatant on a tube rotator for 30 min.</li>
	<li>Centrifuge the tube for 30 min at 13,000 x g and 4 &#176;C.</li>
	<li>Recover the supernatant and measure the protein concentration using the Bradford protein assay, per the manufacturer&#39;s instructions. Store the sample at -80 &#176;C until use.</li>
</ol>

<ol><li>Vogel, C., Marcotte, E. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Insights+into+the+regulation+of+protein+abundance+from+proteomic+and+transcriptomic+analyses%5BTitle%5D)+AND+%22Nat+Rev+Genet%22%5BJournal%5D)">Insights into the regulation of protein abundance from proteomic and transcriptomic analyses.</a> Nat Rev Genet. 13 (4), 227-232 (2012).</li>
<li>de Sousa Abreu, R., Penalva, L. O., Marcotte, E. M., Vogel, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Global+signatures+of+protein+and+mRNA+expression+levels%5BTitle%5D)+AND+%22Mol+Biosyst%22%5BJournal%5D)">Global signatures of protein and mRNA expression levels.</a> Mol Biosyst. 5 (12), 1512-1526 (2009).</li>
<li>Hanash, S. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/12634796">Disease proteomics.</a> Nature. 422 (6928), 226-232 (2003).</li>
<li>Ahram, M., Petricoin, E. F. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/19578516">Proteomics Discovery of Disease Biomarkers.</a> Biomark Insights. 3, 325-333 (2008).</li>
<li>Chandramouli, K., Qian, P. Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Proteomics%3A+challenges%2C+techniques+and+possibilities+to+overcome+biological+sample+complexity%5BTitle%5D)+AND+%22Hum+Genomics+Proteomics%22%5BJournal%5D)">Proteomics: challenges, techniques and possibilities to overcome biological sample complexity.</a> Hum Genomics Proteomics. 2009, (2009).</li>
<li>Singleton, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Recent+advances+in+bioanalytical+sample+preparation+for+LC-MS+analysis%5BTitle%5D)+AND+%22Bioanalysis%22%5BJournal%5D)">Recent advances in bioanalytical sample preparation for LC-MS analysis.</a> Bioanalysis. 4 (9), 1123-1140 (2012).</li>
<li>Williams, T. H., Jew, J. Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Is+the+mitral+valve+passive+flap+theory+overstated%3F+An+active+valve+is+hypothesized%5BTitle%5D)+AND+%22Med+Hypotheses%22%5BJournal%5D)">Is the mitral valve passive flap theory overstated? An active valve is hypothesized.</a> Med Hypotheses. 62 (4), 605-611 (2004).</li>
<li>Rabkin, E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Activated+interstitial+myofibroblasts+express+catabolic+enzymes+and+mediate+matrix+remodeling+in+myxomatous+heart+valves%5BTitle%5D)+AND+%22Circulation%22%5BJournal%5D)">Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves.</a> Circulation. 104 (21), 2525-2532 (2001).</li>
<li>Martins Cde, O., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Distinct+mitral+valve+proteomic+profiles+in+rheumatic+heart+disease+and+myxomatous+degeneration%5BTitle%5D)+AND+%22Clin+Med+Insights+Cardiol%22%5BJournal%5D)">Distinct mitral valve proteomic profiles in rheumatic heart disease and myxomatous degeneration.</a> Clin Med Insights Cardiol. 8, 79-86 (2014).</li>
<li>Tan, H. T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Unravelling+the+proteome+of+degenerative+human+mitral+valves%5BTitle%5D)+AND+%22Proteomics%22%5BJournal%5D)">Unravelling the proteome of degenerative human mitral valves.</a> Proteomics. 15 (17), 2934-2944 (2015).</li>
<li>Banfi, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Proteome+of+platelets+in+patients+with+coronary+artery+disease%5BTitle%5D)+AND+%22Exp+Hematol%22%5BJournal%5D)">Proteome of platelets in patients with coronary artery disease.</a> Exp Hematol. 38 (5), 341-350 (2010).</li>
<li>Banfi, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Proteomic+analysis+of+human+low-density+lipoprotein+reveals+the+presence+of+prenylcysteine+lyase%2C+a+hydrogen+peroxide-generating+enzyme%5BTitle%5D)+AND+%22Proteomics%22%5BJournal%5D)">Proteomic analysis of human low-density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme.</a> Proteomics. 9 (5), 1344-1352 (2009).</li>
<li>Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Protein+measurement+with+the+Folin+phenol+reagent%5BTitle%5D)+AND+%22J+Biol+Chem%22%5BJournal%5D)">Protein measurement with the Folin phenol reagent.</a> J Biol Chem. 193 (1), 265-275 (1951).</li>
<li>Banfi, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Very+low+density+lipoprotein-mediated+signal+transduction+and+plasminogen+activator+inhibitor+type+1+in+cultured+HepG2+cells%5BTitle%5D)+AND+%22Circ+Res%22%5BJournal%5D)">Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type 1 in cultured HepG2 cells.</a> Circ Res. 85 (2), 208-217 (1999).</li>
<li>Brioschi, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Normal+human+mitral+valve+proteome%3A+A+preliminary+investigation+by+gel-based+and+gel-free+proteomic+approaches%5BTitle%5D)+AND+%22Electrophoresis%22%5BJournal%5D)">Normal human mitral valve proteome: A preliminary investigation by gel-based and gel-free proteomic approaches.</a> Electrophoresis. 37 (20), 2633-2643 (2016).</li>
<li>Brioschi, M., Lento, S., Tremoli, E., Banfi, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Proteomic+analysis+of+endothelial+cell+secretome%3A+a+means+of+studying+the+pleiotropic+effects+of+Hmg-CoA+reductase+inhibitors%5BTitle%5D)+AND+%22J+Proteomics%22%5BJournal%5D)">Proteomic analysis of endothelial cell secretome: a means of studying the pleiotropic effects of Hmg-CoA reductase inhibitors.</a> J Proteomics. 78, 346-361 (2013).</li>
<li>Sun, S., Zhou, J. Y., Yang, W., Zhang, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Inhibition+of+protein+carbamylation+in+urea+solution+using+ammonium-containing+buffers%5BTitle%5D)+AND+%22Anal+Biochem%22%5BJournal%5D)">Inhibition of protein carbamylation in urea solution using ammonium-containing buffers.</a> Anal Biochem. 446, 76-81 (2014).</li>
<li>Rabilloud, T., Adessi, C., Giraudel, A., Lunardi, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Improvement+of+the+solubilization+of+proteins+in+two-dimensional+electrophoresis+with+immobilized+pH+gradients%5BTitle%5D)+AND+%22Electrophoresis%22%5BJournal%5D)">Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients.</a> Electrophoresis. 18 (3-4), 307-316 (1997).</li>
<li>Santoni, V., Molloy, M., Rabilloud, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Membrane+proteins+and+proteomics%3A+un+amour+impossible%3F%5BTitle%5D)+AND+%22Electrophoresis%22%5BJournal%5D)">Membrane proteins and proteomics: un amour impossible?</a> Electrophoresis. 21 (6), 1054-1070 (2000).</li>
<li>Shechter, D., Dormann, H. L., Allis, C. D., Hake, S. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Extraction%2C+purification+and+analysis+of+histones%5BTitle%5D)+AND+%22Nat+Protoc%22%5BJournal%5D)">Extraction, purification and analysis of histones.</a> Nat Protoc. 2 (6), 1445-1457 (2007).</li>
<li>Fujiki, Y., Hubbard, A. L., Fowler, S., Lazarow, P. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Isolation+of+intracellular+membranes+by+means+of+sodium+carbonate+treatment%3A+application+to+endoplasmic+reticulum%5BTitle%5D)+AND+%22J+Cell+Biol%22%5BJournal%5D)">Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum.</a> J Cell Biol. 93 (1), 97-102 (1982).</li>
<li>Gorg, A., Weiss, W., Dunn, M. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Current+two-dimensional+electrophoresis+technology+for+proteomics%5BTitle%5D)+AND+%22Proteomics%22%5BJournal%5D)">Current two-dimensional electrophoresis technology for proteomics.</a> Proteomics. 4 (12), 3665-3685 (2004).</li>
<li>Mann, M., Kelleher, N. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Precision+proteomics%3A+the+case+for+high+resolution+and+high+mass+accuracy%5BTitle%5D)+AND+%22Proc+Natl+Acad+Sci+U+S+A%22%5BJournal%5D)">Precision proteomics: the case for high resolution and high mass accuracy.</a> Proc Natl Acad Sci U S A. 105 (47), 18132-18138 (2008).</li>
<li>Thakur, S. S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Deep+and+highly+sensitive+proteome+coverage+by+LC-MS%2FMS+without+prefractionation%5BTitle%5D)+AND+%22Mol+Cell+Proteomics%22%5BJournal%5D)">Deep and highly sensitive proteome coverage by LC-MS/MS without prefractionation.</a> Mol Cell Proteomics. 10 (8), M110.003699(2011).</li>
<li>Loardi, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Biology+of+mitral+valve+prolapse%3A+the+harvest+is+big%2C+but+the+workers+are+few%5BTitle%5D)+AND+%22Int+J+Cardiol%22%5BJournal%5D)">Biology of mitral valve prolapse: the harvest is big, but the workers are few.</a> Int J Cardiol. 151 (2), 129-135 (2011).</li>
<li>Schoen, F. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Evolving+concepts+of+cardiac+valve+dynamics%3A+the+continuum+of+development%2C+functional+structure%2C+pathobiology%2C+and+tissue+engineering%5BTitle%5D)+AND+%22Circulation%22%5BJournal%5D)">Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering.</a> Circulation. 118 (18), 1864-1880 (2008).</li>
<li>Lelovas, P. P., Kostomitsopoulos, N. G., Xanthos, T. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+comparative+anatomic+and+physiologic+overview+of+the+porcine+heart%5BTitle%5D)+AND+%22J+Am+Assoc+Lab+Anim+Sci%22%5BJournal%5D)">A comparative anatomic and physiologic overview of the porcine heart.</a> J Am Assoc Lab Anim Sci. 53 (5), 432-438 (2014).</li>
</ol>

The authors have nothing to disclose.

One critical step of this protocol is the use of liquid nitrogen to freeze the sample and to chill the grinder system. The use of liquid nitrogen prevents biological degradation and allows for efficient powdering, but it requires specific training for safe handling.
In this protocol features a grinder system for sample grinding because small samples are difficult to recover from standard mortar and pestles. In this case, small samples spread as a fine powder over the mortar surface, rendering ...

Recent evidence has altered the understanding of the roles of the many regulatory mechanisms that occur after mRNA synthesis. Indeed, translational, post-transcriptional, and proteolytic processes can regulate protein abundance and function. The dogma &#8211; which says that mRNA concentrations are proxies to those of the corresponding proteins, assuming that transcript levels are the main determinant of protein abundance &#8211; has been partially revised.Indeed, transcript levels only partially predict protein abundance, suggesting that post-transcriptional events occur to regulate the proteins within cells1,2.
Furthermore, proteins ultimately dictate the function of the cell and therefore dictate its phenotype, which can undergo dynamic changes in response to autocrine, paracrine, and endocrine factors; blood-borne mediators; temperature; drug treatment; and disease development. Thus, an expression analysis focused on the protein level is useful to characterize the proteome and to unravel the critical changes that occur to it as part of disease pathogenesis3.
Therefore, the opportunities that proteomics present to clarify health and disease conditions are formidable, despite the existing technological challenges. The particularly promising areas of research to which proteomics can contributeinclude: the identification of altered protein expression at any level (i.e., whole cells or tissue, subcellular compartments, and biological fluids); the identification, verification, and validation of novel biomarkers useful for the diagnosis and prognosis of disease; and, hopefully, the identification of new protein targets that can be used for therapeutic purposes, as well as for the assessment of drug efficacy and toxicity4.
Capturing the complexity of the proteome represents a technological challenge. The current proteomic tools offer the opportunity to perform large-scale, high-throughput analysis for the identification, quantification, and validation of altered protein levels. In addition, the introduction of fractionation and enrichment techniques, aimed at avoiding the interference caused by the most abundant proteins, has also improved protein identification by including the least abundant proteins. Finally, proteomics has been complemented by the analysis of post-translational modifications, which progressively emerge as important modulators of protein function.
However, the sample preparation and protein recovery in the biological specimens under analysis still remain the limiting steps in the proteomic workflow and increase the potential for possible pitfalls5. Indeed,in most of the molecular biology techniques that must be optimized, the first steps are tissue homogenization and cell lysis, especially during the analysis of low-abundance proteins for which amplification methods do not exist. In addition, the chemical nature of proteins can influence their own recovery. For example, the analysis of highly hydrophobic proteins is very challenging, because they easily precipitate during isoelectric focusing, while trans-membrane proteins are almost insoluble (reviewed in Reference 5). Furthermore, the tissue composition variability creates a significant barrier to developing a universal extraction method. Finally, because almost all of the clinical specimens are of limited quantity, it is essential to enable protein preparation with maximal recovery and reproducibility from minimal sample amounts6.
This work describes an optimized protocol for protein extraction from the normal human cardiac mitral valve, which represents a very challenging sample for proteomic analysis. The normal mitral valve is a complex structure lying between the left atrium and the left ventricle of the heart (Figure 1). It plays an important role in the control of blood flow from the atrium to the ventricle, preventing backflow and ensuring the proper level of oxygen supply to the whole body, thus maintaining an adequate cardiac output. However, it is often considered to be an &#34;inactive&#34; tissue, with a low cellularity and few components, mainly in the extracellular matrix. This is because, in normal conditions, the resident valvular interstitial cells (VICs) present a quiescent phenotype with a low protein biosynthesis rate7.
However, it has been demonstrated that, in a pathological state, the number of VICs in the spongiosa increases and their protein synthesis is activated, together with other functional and phenotypical changes8. Therefore, it is not surprising that the minimal data available in the literature focus on the analysis of pathological mitral valves9,10, in which the increased number of activated VICs might explain the relatively high number of identified proteins.
In conclusion, the present protocol may serve to develop the understanding of the pathogenic mechanisms responsible for mitral valve diseases through the study of mitral valve protein components. Indeed, a greater understanding of the underlying pathological processes could help to improve the clinical management of valve diseases, whose current indications for intervention are largely predicated on hemodynamic considerations.

<table><tbody><tr><td>Saline solution</td><td></td><td></td><td>0.9 % NaCl</td></tr><tr><td>Eurocollins A</td><td>SALF</td><td>30874046</td><td>Balanced organ&#039;s transport medium. Combine 400 mL of Eurocollins A with 100 mL Eurocollins B to obtain balanced medium Eurocollins</td></tr><tr><td>Eurocollins B</td><td>SALF</td><td>30874022</td><td>Balanced organ&#039;s transport medium. Combine 400 mL of Eurocollins A with 100 mL Eurocollins B to obtain balanced medium Eurocollins</td></tr><tr><td>Wisconsin</td><td>Bridge life</td><td>RM/N 4081</td><td>Balanced organ&#039;s transport medium</td></tr><tr><td>Biohazard vertical flow air</td><td>Burdinola</td><td></td><td>Class A GMP classification</td></tr><tr><td>Dewar Flask</td><td>Thermo Scientific</td><td>Nalgene 4150-1000</td><td></td></tr><tr><td>Cryogrinder system</td><td>OPS diagnostics</td><td>CG 08-01</td><td>Grinder system containing mortars, pestles and screwdriver</td></tr><tr><td>Stainless steel forceps</td><td></td><td></td><td></td></tr><tr><td>Stainless steel spatula</td><td></td><td></td><td></td></tr><tr><td>Disposable sterile scalpel</td><td>Medisafe</td><td>MS-10</td><td></td></tr><tr><td>Stainless steel scissors</td><td></td><td></td><td>Autoclavable</td></tr><tr><td>Stainless steel picks</td><td></td><td></td><td>Autoclavable</td></tr><tr><td>Disposable sterile drap</td><td>Mon&amp;amp;Tex</td><td>3.307.08</td><td></td></tr><tr><td>Sterilizing solution with isopropyl alcohol</td><td></td><td></td><td>70% isopropyl alcohol</td></tr><tr><td>Sterilizing solution with hydrogen peroxide</td><td></td><td></td><td>6% hydrogen peroxide</td></tr><tr><td>Micropipette, 1 mL, with tips</td><td></td><td></td><td></td></tr><tr><td>15 mL centrifuge tubes</td><td>VWR international</td><td>9278</td><td></td></tr><tr><td>1.7 mL centrifuge tubes</td><td>VWR international</td><td>PIER90410</td><td></td></tr><tr><td>Urea buffer</td><td></td><td></td><td>8 M urea, 2 M thiourea, 4 % w/v CHAPS, 20 mM Trizma, 55 mM Dithiotreitol</td></tr><tr><td>Urea</td><td>Sigma aldrich</td><td>U6504-1KG</td><td>To be used for Urea buffer</td></tr><tr><td>Thiourea</td><td>Sigma aldrich</td><td>T8656</td><td>To be used for Urea buffer</td></tr><tr><td>CHAPS</td><td>Sigma aldrich</td><td>C3023-5GR</td><td>To be used for Urea buffer</td></tr><tr><td>Dithiotreitol</td><td>Sigma aldrich</td><td>D0632-5G</td><td>To be used for Urea buffer</td></tr><tr><td>Syringe 50 mL</td><td>PIC</td><td></td><td>To be used to filter Urea buffer</td></tr><tr><td>0.22 &amp;micro;m filter</td><td>Millipore</td><td>SLGP033RB</td><td>To be used to filter Urea buffer</td></tr><tr><td>PFTE Pestle, 2 mL</td><td>Kartell</td><td>6302</td><td>Part of Potter-Elvehjem homogenizer</td></tr><tr><td>Borosilicate glass mortar</td><td>Kartell</td><td>6102</td><td>Part of Potter-Elvehjem homogenizer</td></tr><tr><td>Stirrer</td><td>VELP scientifica</td><td>Stirrer DLH</td><td>To be used for homogenization by Potter-Elvehjem</td></tr><tr><td>Bradford Protein assay</td><td>Bio-Rad laboratories</td><td>5000006</td><td></td></tr><tr><td>Tube rotator</td><td>Pbi International</td><td>F205</td><td></td></tr><tr><td>Liquid nitrogen</td><td></td><td></td><td></td></tr><tr><td>Aluminum foil</td><td></td><td></td><td></td></tr><tr><td>Ice</td><td></td><td></td><td></td></tr><tr><td>Polystyrene box</td><td></td><td></td><td></td></tr><tr><td>Dry ice</td><td></td><td></td><td></td></tr><tr><td>Centrifuge</td><td></td><td></td><td>For centrifugation of 1.7 mL centrifuge tubes at 13,000 x g</td></tr><tr><td>Freezer -80&amp;deg;C</td><td></td><td></td><td></td></tr><tr><td>Precision balance</td><td></td><td></td><td></td></tr><tr><td>Autoclave</td><td></td><td></td><td>For sterilization</td></tr><tr><td>Cryogenic gloves for liquid nitrogen</td><td></td><td></td><td></td></tr><tr><td>Gloves</td><td></td><td></td><td></td></tr><tr><td>Professional forced ventilation and natural air convection oven</td><td></td><td></td><td>For sterilization</td></tr><tr><td>Protease inhibitor cocktail</td><td>Sigma aldrich</td><td>P8340-5ML</td><td>100X solution</td></tr><tr><td>ProteoExtract Protein Precipitation Kit</td><td>Calbiochem</td><td>539180</td><td></td></tr><tr><td>RapiGest</td><td>Waters</td><td>186001861</td><td></td></tr><tr><td>Cytoscape</td><td>www.cytoscape.org</td><td>version 2.7</td><td>Software platform for Gene Ontology analysis</td></tr><tr><td>BiNGO</td><td>http://apps.cytoscape.org/apps/bingo</td><td>version 3.0.3</td><td>Plugin for Gene ontology analysis</td></tr><tr><td>AlphaB Crystallin/CRYAB Antibody</td><td>Novus Biologicals</td><td>NBP1-97494</td><td>Mouse monoclonal antibody against CryAB</td></tr><tr><td>Septin-11 Antibody</td><td>Novus Biologicals</td><td>NBP1-83824</td><td>Rabbit polyclonal antibody against septin-11</td></tr><tr><td>FHL1 Antibody</td><td>Novus Biologicals</td><td>NBP-188745</td><td>Rabbit polyclonal antibody against FHL-1</td></tr><tr><td>Dermatopontin Antibody</td><td>Novus Biologicals</td><td>NB110-68135</td><td>Rabbit polyclonal antibody against dermatopontin</td></tr><tr><td>Goat Anti mouse IgG HRP</td><td>Sigma aldrich</td><td>A4416-0.5ML</td><td>Secondary antibody for immunoblotting</td></tr><tr><td>Goat Anti rabbit IgG HRP</td><td>Bio-Rad laboratories</td><td>170-5046</td><td>Secondary antibody for immunoblotting</td></tr></tbody></table>

optimized protocol for the extraction of proteins from the human mitral valve

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Analysis of the cellular proteome can help to elucidate the molecular mechanisms underlying diseases due to the development of technologies that permit the large-scale identification and quantification of the proteins present in complex biological systems.The knowledge gained from a proteomic approach can potentially lead to a better understanding of the pathogenic mechanisms underlying diseases, allowing for the identification of novel diagnostic and prognostic disease markers, and, hopefully, of therapeutic targets. However, the cardiac mitral valve represents a very challenging sample for proteomic analysis because of the low cellularity in proteoglycan and collagen-enriched extracellular matrix. This makes it challenging to extract proteins for a global proteomic analysis. This work describes a protocol that is compatible with subsequent protein analysis, such as quantitative proteomics and immunoblotting. This can allow for the correlation of data concerning protein expression with data on quantitative mRNA expression and non-quantitative immunohistochemical analysis. Indeed, these approaches, when performed together, will lead to a more comprehensive understanding of the molecular mechanisms underlying diseases, from mRNA to post-translational protein modification. Thus, this method can be relevant to researchers interested in the study of cardiac valve physiopathology.

The extraction and dissolution of proteins in the urea buffer is directly compatible with proteomic methods based on isoelectrofocusing (two-dimensional electrophoresis (2-DE)11 and liquid-phase isoelectric focusing (IEF)12) and with immunoblotting after dilution in Laemmli buffer13 containing a protease inhibitor cocktail14.
For gel-...

The protein composition of the human mitral valve is still partially unknown, because its analysis is complicated by low cellularity and therefore by low protein biosynthesis. This work provides a protocol to efficiently extract protein for the analysis of the mitral valve proteome.

Analysis of the cellular proteome can help to elucidate the molecular mechanisms underlying diseases due to the development of technologies that permit ...

The overall goal of this procedure is to efficiently extract proteins from the human cardiac mitral valve, suitable for proteomic analysis. This method can potentially help uncover pathogenic mechanisms in the field of cardiac valve disease, allowing for identification of novel diagnostic and prognostic disease markers and hopefully, of therapeutic targets. The main advantage of this protocol is that it provides an efficient extraction workflow compatible with many analytical applications.The results being a more exhaustive characterization of the cardiac mitral valve proteum. Moreover, this protocol can also be applied to other systems, such as the porcine mitral valve, which bears a close resemblance to the human valve and is used in experimental model for valve function evaluations. Demonstrating the experimental procedure will be Stefania Ghilardi, a technician from my laboratory.to prepare the human mitral valve, begin with an explanted heart that has been under cold ischemia for four to 12 hours. In a Cleanroom, remove the heart from the transport bag, and put it into a sterilized bucket. Next, transfer the heart to a biosafety cabinet.There, using a disposable scalpel, cut p

optimized-protocol-for-extraction-proteins-from-human-mitral

Research

JoVE Journal

Biochemistry

The analysis of protein expression in young embryonic mouse valves has been hampered by the limited tissue available. This manuscript provides a protocol for preparing protein from developing embryonic mouse valve regions for western blot analysis.

Protein Isolation from the Developing Embryonic Mouse Heart Valve Region

We have established a method for the purification of coregulatory interaction proteins using the LC-MS/MS system.

A Protein Preparation Method for the High-throughput Identification of Proteins Interacting with a Nuclear Cofactor Using LC-MS/MS Analysis

Here, we present an interactome capture protocol applied to Arabidopsis thaliana leaf mesophyll protoplasts. This method critically relies on in vivo UV crosslinking and allows for the isolation and identification of plant mRNA-binding proteins from a physiological environment.

mRNA Interactome Capture from Plant Protoplasts

As mitochondria are only a small percentage of the plant cell, they need to be purified for a range of studies. Mitochondria can be isolated from a variety of plant organs by homogenization, followed by differential and density gradient centrifugation to obtain a highly purified mitochondrial fraction.

Isolation and Respiratory Measurements of Mitochondria from Arabidopsis thaliana

Mitochondria have specialized ribosomes that diverged from their bacterial and cytoplasmic counterparts. Here we show how mitoribosomes can be obtained from their native compartment in HEK cells. The method involves isolation of mitochondria from suspension cells and consequent purification of mitoribosomes.

Rapid Isolation of the Mitoribosome from HEK Cells

Here we present a protocol to perform polysome profiling on the isolated perfused mouse heart. We describe methods for heart perfusion, polysome profiling, and analysis of the polysome fractions with respect to mRNAs, miRNAs, and the polysome proteome.

Dynamic Proteomic and miRNA Analysis of Polysomes from Isolated Mouse Heart After Langendorff Perfusion

This protocol describes a single throughput for complementary analytical and omics techniques culminating in a fully-paired characterization of natural organic matter and microbial proteomics in different ecosystems. This approach permits robust comparisons for identifying metabolic pathways and transformations important for describing greenhouse gas production and predicting responses to environmental change.

Single-throughput Complementary High-resolution Analytical Techniques for Characterizing Complex Natural Organic Matter Mixtures

Here we present a protocol to extract, resolve and identify mitochondrial supercomplexes which minimizes exposure to detergents and Coomassie Blue. This protocol offers an optimal balance between resolution, and preservation of enzyme activities, while minimizing the risk of losing labile protein-protein interactions.

Hybrid Clear/Blue Native Electrophoresis for the Separation and Analysis of Mitochondrial Respiratory Chain Supercomplexes

We present a two-step protocol for high-quality mitochondria isolation that is compatible with protein discovery and quantification at a proteome scale. Our protocol does not require genetic engineering and is thus suitable for studying mitochondria from any primary cells and tissues.

Two-Step Tag-Free Isolation of Mitochondria for Improved Protein Discovery and Quantification

Bioenergetic and metabolomic studies on mitochondria have revealed their multifaceted role in many diseases, but the isolation methods for these organelles vary. The method detailed here is capable of purifying high-quality mitochondria from multiple tissue sources. Quality is determined by respiratory control ratios and other metrics assessed with high-resolution respirometry.

Robust Mitochondrial Isolation from Rodent Cardiac Tissue

Learn an optimized protein extraction protocol for the human cardiac mitral valve suitable for proteomic analysis. This method enables comprehensive proteome characterization and identification of diagnostic markers in valvular heart disease.

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Explore More Videos